09-274
Anti-PEAK1 Antibody
from rabbit, purified by affinity chromatography
別名:
NKF3 kinase family member, Sugen kinase 269
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
polyclonal
Application:
WB
Citations:
4
biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
human
technique(s)
western blot: suitable
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Quality Level
Gene Information
human ... PEAK1(79834)
General description
250 kDa
PEAK1 belongs to the protein kinase superfamily. PEAK1 is also called Tyrosine-protein kinase SgK269 and Sugen kinase 269. It contains a divergent and possibly inactive eukaryotic protein kinase domain. It has one human paralog, known as SgK223 or pragmin. These two constitute the NKF3 subfamily of protein kinases, found in vertebrates and echinoderms.
Immunogen
Epitope: 1511-1660 aa
Recombinant Protein, aa: 1511-1660. Homology: 100% human and chimp; 96% pig and horse; 90% mouse; 88% rat
Application
This Anti-PEAK1 Antibody is validated for use in WB for the detection of PEAK1.
Biochem/physiol Actions
Other species have not been tested.
Analysis Note
Control
FG Nonstim /Nonstrvd lysate
FG Nonstim /Nonstrvd lysate
Routinely evaluated by Western Blot on FG Nonstim /Nonstrvd lysate.
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
保管分類
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
09-274:
jan
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Exosome-delivered circSATB2 targets the miR-330-5p/PEAK1 axis to regulate proliferation, migration and invasion of lung cancer cells.
Zhu, et al.
Thoracic cancer, 13, 3007-3017 (2023)
Ken Fujimura et al.
Cancer research, 78(6), 1444-1456 (2018-01-13)
There remains intense interest in tractable approaches to target or silence the KRAS oncoprotein as a rational therapeutic strategy to attack pancreatic ductal adenocarcinoma (PDAC) and other cancers that overexpress it. Here we provide evidence that accumulation of the KRAS
Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.
Aguilera, KY; Rivera, LB; Hur, H; Carbon, JG; Toombs, JE; Goldstein, CD; Dellinger et al.
Cancer Research null
Kristina Y Aguilera et al.
Molecular cancer therapeutics, 16(11), 2473-2485 (2017-09-03)
The extracellular matrix (ECM), a principal component of pancreatic ductal adenocarcinoma (PDA), is rich in fibrillar collagens that facilitate tumor cell survival and chemoresistance. Discoidin domain receptor 1 (DDR1) is a receptor tyrosine kinase that specifically binds fibrillar collagens and
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| 09-274 | 04053252319228 |
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）